secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001193125-23-148212
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio prices $87M public offering of 7.25M shares at $12.00 per share
-----------------------------------------------------------------------------

- Pricing of 7,250,000 shares at $12.00 per share; gross proceeds expected $87M before expenses.
- Underwriters granted 30-day option for up to an additional 1,087,500 shares.
- Net proceeds estimated at $81.18M after underwriting discounts and offering expenses.
- Proceeds to fund expanded clinical development of CABA-201, manufacturing, and CAART programs.
- Offering expected to close May 22, 2023; TD Cowen, Evercore ISI, Guggenheim lead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523148212/0001193125-23-148212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523148212/d408961d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-148212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer